| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.
|
J Clin Invest
|
2003
|
3.62
|
|
2
|
Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
|
J Clin Endocrinol Metab
|
2006
|
2.72
|
|
3
|
Pharmacological management of obesity: an endocrine Society clinical practice guideline.
|
J Clin Endocrinol Metab
|
2015
|
2.05
|
|
4
|
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
|
J Clin Endocrinol Metab
|
2005
|
1.73
|
|
5
|
The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome.
|
Ann N Y Acad Sci
|
2006
|
1.53
|
|
6
|
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance.
|
Cell Metab
|
2010
|
1.33
|
|
7
|
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
|
Clin Endocrinol (Oxf)
|
2004
|
1.29
|
|
8
|
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
|
Endocrinology
|
2006
|
1.27
|
|
9
|
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.
|
Diabetes
|
2008
|
1.25
|
|
10
|
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression.
|
Cancer Res
|
2006
|
1.24
|
|
11
|
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
|
J Clin Endocrinol Metab
|
2006
|
1.19
|
|
12
|
Stress-related development of obesity and cortisol in women.
|
Obesity (Silver Spring)
|
2009
|
1.14
|
|
13
|
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.
|
Diabetes
|
2004
|
1.14
|
|
14
|
Body mass index-independent metabolic alterations in narcolepsy with cataplexy.
|
Sleep
|
2009
|
1.13
|
|
15
|
Energy balance regulation by endocannabinoids at central and peripheral levels.
|
Trends Mol Med
|
2011
|
1.07
|
|
16
|
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults.
|
Steroids
|
2010
|
1.06
|
|
17
|
Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.
|
Diabetes
|
2010
|
0.99
|
|
18
|
Ghrelin as a potential anti-obesity target.
|
Curr Pharm Des
|
2003
|
0.98
|
|
19
|
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.
|
Proc Natl Acad Sci U S A
|
2013
|
0.96
|
|
20
|
Cortisol, energy intake, and food frequency in overweight/obese women.
|
Nutrition
|
2010
|
0.96
|
|
21
|
The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake.
|
PLoS One
|
2013
|
0.96
|
|
22
|
Glucocorticoids and type 2 diabetes: from physiology to pathology.
|
J Nutr Metab
|
2012
|
0.96
|
|
23
|
Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
|
Eur J Endocrinol
|
2012
|
0.96
|
|
24
|
Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity.
|
Obesity (Silver Spring)
|
2006
|
0.95
|
|
25
|
Here, there and everywhere: the endocannabinoid system.
|
J Neuroendocrinol
|
2008
|
0.95
|
|
26
|
Autonomic disturbances in narcolepsy.
|
Sleep Med Rev
|
2010
|
0.95
|
|
27
|
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS.
|
J Lipid Res
|
2011
|
0.94
|
|
28
|
Circulating obestatin levels and the ghrelin/obestatin ratio in obese women.
|
Eur J Endocrinol
|
2007
|
0.93
|
|
29
|
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2006
|
0.93
|
|
30
|
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2010
|
0.93
|
|
31
|
High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy.
|
Sleep
|
2013
|
0.92
|
|
32
|
Predictors of weight loss and maintenance in patients treated with antiobesity drugs.
|
Diabetes Metab Syndr Obes
|
2011
|
0.92
|
|
33
|
Central effects of the somatotropic system.
|
Eur J Endocrinol
|
2003
|
0.92
|
|
34
|
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome.
|
Eur J Endocrinol
|
2010
|
0.89
|
|
35
|
Leucine supplementation protects from insulin resistance by regulating adiposity levels.
|
PLoS One
|
2013
|
0.89
|
|
36
|
Active and total ghrelin concentrations in the newborn.
|
J Pediatr Endocrinol Metab
|
2005
|
0.88
|
|
37
|
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.
|
Cardiovasc Ther
|
2011
|
0.87
|
|
38
|
A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
|
Eur J Endocrinol
|
2011
|
0.87
|
|
39
|
Ghrelin and reproductive disorders.
|
Mol Cell Endocrinol
|
2011
|
0.87
|
|
40
|
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells.
|
J Clin Endocrinol Metab
|
2003
|
0.87
|
|
41
|
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.
|
Diabetes
|
2012
|
0.87
|
|
42
|
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis.
|
Clin Endocrinol (Oxf)
|
2007
|
0.84
|
|
43
|
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly.
|
Int J Cancer
|
2009
|
0.84
|
|
44
|
(11)C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion.
|
Mol Metab
|
2013
|
0.83
|
|
45
|
Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levels.
|
Endocrinology
|
2009
|
0.83
|
|
46
|
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
|
Curr Opin Pharmacol
|
2006
|
0.83
|
|
47
|
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
|
Clin Nucl Med
|
2011
|
0.82
|
|
48
|
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2007
|
0.81
|
|
49
|
Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study.
|
Sleep
|
2011
|
0.81
|
|
50
|
Role of sex hormones in modulation of brown adipose tissue activity.
|
J Mol Endocrinol
|
2012
|
0.80
|
|
51
|
Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students.
|
J Clin Endocrinol Metab
|
2013
|
0.80
|
|
52
|
The endocannabinoid system in the regulation of cardiometabolic risk factors.
|
Am J Cardiol
|
2007
|
0.79
|
|
53
|
Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women.
|
J Clin Endocrinol Metab
|
2013
|
0.79
|
|
54
|
The unrelenting fall of the pharmacological treatment of obesity.
|
Endocrine
|
2013
|
0.78
|
|
55
|
Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2005
|
0.78
|
|
56
|
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states.
|
Horm Mol Biol Clin Investig
|
2014
|
0.77
|
|
57
|
Feeding disorders and obesity.
|
Curr Top Behav Neurosci
|
2009
|
0.76
|
|
58
|
Brain PET imaging in obesity and food addiction: current evidence and hypothesis.
|
Obes Facts
|
2012
|
0.76
|
|
59
|
Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women.
|
Horm Mol Biol Clin Investig
|
2015
|
0.76
|
|
60
|
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease.
|
Eur J Endocrinol
|
2005
|
0.75
|
|
61
|
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.
|
Rev Endocr Metab Disord
|
2013
|
0.75
|
|
62
|
Aldosterone and type 2 diabetes mellitus.
|
Horm Mol Biol Clin Investig
|
2016
|
0.75
|
|
63
|
Guiding clinical decisions on abdominal obesity and cardiometabolic risk.
|
Clin Cornerstone
|
2009
|
0.75
|
|
64
|
The endocannabinoid system as a target for obesity treatment.
|
Clin Cornerstone
|
2008
|
0.75
|